News 2011
Congressional Briefing Pushes for Prioritization of Black Women
At congressional in October, the National Black Leadership Commission on AIDS (NBLCA) debuted its groundbreaking documentary Many Women, One Voice, about Black women and HIV/AIDS. After the screening, members of Congress, their staffers, employees of AIDS non-profits and HIV/AIDS advocates discussed the importance of Black women's involvement in the leadership of the HIV/AIDS movement.
Read more: Congressional Briefing Pushes for Prioritization of Black Women
Meet Gail Butler, the new COO of the Black AIDS Institute
Don't call it a comeback, but the former California state executive director of Mothers Against Drunk Driving (MADD) has embarked upon an encore career as chief operating officer of the Black AIDS Institute. We asked this 58-year-old attorney and public health professional about her involvement in the fight against HIV/AIDS, the mission of the Institute and the goals she seeks to accomplish in her new position.
Read more: Meet Gail Butler, the new COO of the Black AIDS Institute
The Black AIDS Institute Congratulates President Obama for Implementing New Measures to End the AIDS Epidemic in America
Today, World AIDS Day 2011, the Black AIDS Institute congratulates President Obama for continuing to fulfill his commitment to create an "AIDS-free generation" by making several significant commitments to move us closer to ending the domestic epidemic.
Secretary Sebelius appoints Nancy Mahon, Executive Director of MAC AIDS Fund, as Chair of the Presidential Advisory Council on HIV/AIDS
Health and Human Services Secretary Kathleen Sebelius today announced the appointment of Nancy Mahon as the new Chair of the Presidential Advisory Council on HIV/AIDS (PACHA). Ms. Mahon, executive director of the M·A·C AIDS Fund, has many years of experience in leading large philanthropic endeavors. In her role as chair, she will maintain the continuity of PACHA-related activities and, on occasion, represent the administration at PACHA-related events.
NIH Discontinues Tenofovir Vaginal Gel in 'VOICE' HIV Prevention Study
Product Safe but No More Effective than Placebo
A large-scale clinical trial evaluating whether daily use of an antiretroviral-containing oral tablet or vaginal gel can prevent HIV infection in women is being modified because an interim review found that the gel, an investigational microbicide, was not effective among study participants.
Read more: NIH Discontinues Tenofovir Vaginal Gel in 'VOICE' HIV Prevention Study